We specialize in developing new tools for stem cells research, including cancer stem cells.
The patented biomarker GlioStem is intended for the detection and visualization of stem cell-like cells in brain tumors. Today, there are no products on the market that target stem cell-like cells in these tumors. The goal for GlioStem is to be used during surgery to completely remove tumor tissue and thereby lead to increased patient survival and quality of life.
GlioStem is a new product designed for near-instant detection of glioma stem cells.
It is based on polymer technology and defines a new generation of cell type markers.